Psybio Therapeutics Corp
OTC:PSYBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Psybio Therapeutics Corp
OTC:PSYBF
|
CA |
|
S
|
Sands China Ltd
XMUN:599A
|
MO |
|
H
|
Hyatt Hotels Corp
XMUN:1HTA
|
US |
|
P
|
Piraeus Port Authority SA
ATHEX:PPA
|
GR |
|
Systemair AB
F:52SA
|
SE |
|
RITES Ltd
NSE:RITES
|
IN |
|
E
|
Escalade Inc
F:ED9
|
US |
|
P
|
Principal Financial Group Inc
XMUN:PG4
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Psybio Therapeutics Corp.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Psybio Therapeutics Does
PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-02-08. The firm is developing a new class of drugs intended for the treatment of mental health challenges and other disorders. The firm is in the process of developing its portfolio of product candidates for sale in the pharmaceutical industry.
- Headquarters
- Canada CA
- IPO date
- Feb 8, 2011